tirzepatide for weight loss canada Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major market Tirzepatide GLP-1 Weight Loss Program
Description
Data-driven treatment selection
It is about making informed choices that protect what you have already built
Adams, T
Subgroup analysis from SURMOUNT trials shows no significant difference in weight loss outcomes between men and women when controlling for other variables
Medically reviewed by: Jayden Lee, PharmD, EMBA Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes
